NCT03173248 2025-11-10
AGILE
Servier
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT04056910 2025-02-27
Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors
University of Pittsburgh
Phase 2 Completed
NCT02989857 2024-08-20
ClarIDHy
Servier
Phase 3 Completed
NCT04088188 2024-05-06
Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma
Academic and Community Cancer Research United
Phase 1 Terminated